semaglutide 2 mg/1.5ml Ozempic® mg Injection 1 Pen 1 Pen Sematrinity 2mg Pre-filled Pen| Advanced

GSSG, oxidised glutathione

Report any suspected side effects to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk

Many patients report that certain foods become unappealing once semaglutide is active

It serves to provide the body with the necessary nutrients that are consumed during intensive training

Monitoring and Follow-Up Establish a structured monitoring schedule: Monthly visits during dose titration and the first 6 months Quarterly visits once stable, assessing weight, tolerability, and metabolic parameters Annual comprehensive evaluation including lipid panel, HbA1c (if diabetic), liver function tests, and cardiovascular risk assessment Regular monitoring allows early identification of plateaus, adverse effects, or emerging medical issues that may require intervention